Back to mobile site

Tarsus Pharmaceuticals to acquire Alkeus for up to $800M

August 6, 2026 7:01 AM EDT Send to a Friend
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) announced a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held biotechnology company developing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login